Next Article in Journal
Immunomodulatory Effects of the Tobacco Defensin NaD1
Previous Article in Journal
Evaluating the Efficacy of Inhaled Colistin via Two Nebulizer Types in Ventilator-Associated Pneumonia: Prospective Randomized Trial
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Proteomic Analysis of Vibrio parahaemolyticus-Stimulated Pinctada martensii Proteins for Antimicrobial Activity, Potential Mechanisms, and Key Components

1
College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China
2
National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Ocean University, Zhanjiang 524088, China
3
Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Ocean University, Zhanjiang 524088, China
4
Guangdong Province Engineering Laboratory for Marine Biological Products, Guangdong Ocean University, Zhanjiang 524088, China
*
Author to whom correspondence should be addressed.
Antibiotics 2024, 13(11), 1100; https://doi.org/10.3390/antibiotics13111100
Submission received: 18 September 2024 / Revised: 31 October 2024 / Accepted: 18 November 2024 / Published: 19 November 2024

Abstract

:
Background: Bacterial infections are a major challenge in food processing and public health, and there is an urgent need to develop novel antimicrobial agents. Objectives: The purpose of this study is to investigate the potential mechanism and key components of Pinctada martensii antimicrobial proteins (Pm-Aps) to provide a theoretical basis for the development of novel antimicrobial agents. Methods: The researchers used Vibrio parahaemolyticus (VP) to stimulate Pinctada martensii, extracted the antimicrobial proteins, and analyzed their antimicrobial activities, potential mechanisms of action, and key components using proteomics. Results: The results showed that the antimicrobial activity of Pm-Aps, with broad-spectrum antimicrobial effects, was significantly enhanced after VP stimulation. This was associated with the upregulation of LAAO, CHDH, TLR2, ATG16L1, BAK, CLCA4, and CASP8 and the downregulation of MCM3, MCM5, DTYMK, PLK1, FBXO6, LPCAT3, GST, LAMTOR5, CYP17A, CTSA, and RRM1. It is hypothesized that these proteins may inhibit bacterial growth and multiplication by activating immune-related signaling pathways, inhibiting DNA replication and repair, and inducing apoptosis and autophagy. Furthermore, it was found that LAAO may be a key component of the antimicrobial action of Pm-Aps, killing bacteria by catalyzing the oxidation of amino acids to produce hydrogen peroxide (H2O2). Conclusions: These results strongly suggest that Pm-Aps is an effective antimicrobial protein, and it is expected that new LAAO can be obtained from Pm-Aps.

1. Introduction

Bacterial infections not only cause inflammatory diseases [1,2] but also cause serious losses in aquaculture and food processing [3,4]. For example, Vibrio parahaemolyticus, Bacillus cereus, Staphylococcus aureus, Escherichia coli, and Listeria monocytogenes have been associated with food poisoning incidents and are particularly hazardous to the quality and safety of raw meat products, especially aquatic products [5]. Vibrio parahaemolyticus, Streptococcus agalactiae, and Streptococcus iniae cause diseases in aquaculture, resulting in significant economic losses to the aquaculture industry [6,7]. Pseudomonas aeruginosa can infect immunocompromised individuals, causing disease [8]. Currently, antibiotics are one of the most commonly used antimicrobial agents to fight bacterial infections with a broad-spectrum antimicrobial effect. However, the misuse of antibiotics has led to increasing bacterial resistance, making them less effective and posing a huge challenge [9]. Thus, there is an urgent need for a novel antimicrobial agent with high anti-drug-resistant bacterial activity.
Natural antimicrobial agents include alkaloids, glycosides, flavonoids, bacteriocins, antimicrobial peptides, and antimicrobial proteins [10,11,12]. Among them, antimicrobial proteins have different mechanisms of action than antibiotics. Most of the antimicrobial proteins inhibit the growth of bacterial cells through membrane destabilization and membrane pore formation [13,14]. In addition to targeting membranes, antimicrobial proteins also target various intracellular biosynthetic processes in bacteria, such as the biosynthesis of proteins, DNA, and RNA [15]. Furthermore, antimicrobial proteins defend against bacterial infection by inducing apoptosis and autophagy as well as regulating the secretion of relevant inflammatory factors [16]. Hence, it is difficult for bacteria to develop resistance to them. Meanwhile, natural antimicrobial proteins are characterized by safety, high stability, and high biocompatibility, which have the potential to become an alternative to antibiotics [17]. To date, the extraction of natural proteins from nature for antimicrobial use has proven to be useful. For example, lactoferrin has antimicrobial activity against a variety of bacteria, including flesh-eating bacteria, Listeria monocytogenes, and Escherichia coli [18]. Antimicrobial peptides from Litopenaeus vannamei inhibit the growth of gram-negative and gram-positive bacteria [19]. Currently, antimicrobial proteins play an important role in the field of antimicrobial agents due to their excellent antimicrobial functions.
Animals produce a number of humoral defense factors, such as antimicrobial proteins, when stimulated by microorganisms or toxic substances in their natural environment. Therefore, stimulation to induce the production of antimicrobial proteins in animals and to explore their antimicrobial mechanisms is commonly used [20,21]. Pinctada martensii, as one of the major pearl brooding shells, is often infected by Vibrio parahaemolyticus during the insertion of nuclei for pearl brooding, causing its gill tissues to secrete large amounts of antimicrobial proteins [22]. The trypsin serine protease of Pinctada martensii has been found to kill bacteria by disrupting their cell membranes [23], and the histone 2A-derived antimicrobial peptide exerts its antimicrobial activity through membrane cleavage [24]. However, the activity of the antimicrobial proteins of Pinctada martensii is not high, and the mechanism of action is not obvious. In addition, the gill tissue, which is often discarded as a by-product after the removal of beads from Pinctada martensii, can be utilized for high-value processing by using it to extract antimicrobial proteins.
Therefore, in this study, Vibrio parahaemolyticus was injected to imitate the microbial infections of Pinctada martensii in its natural environment, to induce the production of antimicrobial proteins in its gill tissues, and to determine its antimicrobial activity. We also analyzed the expression of different proteins in the gill tissues before and after induction using proteomics to explore the potential mechanisms associated with the antimicrobial effects of Pinctada martensii antimicrobial proteins (Pm-Aps) and to identify the effective key components. The present study provides a theoretical basis for the development of Pm-Aps in the field of natural antimicrobial agents. Meanwhile, it provides some new ideas for the study of inducing the production of antimicrobial proteins using immunostimulation methods.

2. Results

2.1. Effect of VP-Stimulated Infection on Pm-Aps Activity

The inhibitory activity was determined using equal concentrations of giVP- and giC-extracted Pm-Aps solutions, and the results are shown in Figure 1. giVP produced an inhibitory circle with a diameter of (11.51 ± 0.54) mm, and the diameter of the inhibitory circle of giC was (8.23 ± 0.22) mm, which indicated that stimulation of the infection by VP resulted in a significant increase in the activity of Pm-Aps, and it was greater than that of the PC group.

2.2. Antimicrobial Spectrum and Antimicrobial Activity of Pm-Aps

We found that Pm-Aps had an inhibitory effect on VP, and the activity of Pm-Aps produced after induction by VP stimulation was enhanced. To further understand the antimicrobial effect of giVP-extracted Pm-Aps, its antimicrobial spectrum and antimicrobial activity were determined. As shown in Table 1, Pm-Aps produced a zone of inhibition against all bacteria tested. The strongest inhibitory effect of Pm-Aps was observed against VP, while the weakest inhibitory effect was observed against EC. The antimicrobial activity of Pm-Aps was determined using an IT, which showed that Pm-Aps had the highest antimicrobial activity against VP (IT = 16) and the lowest antimicrobial activity against BC, EC, PA, SE, and SI (IT = 4).

2.3. Differential Protein Expression Screening of Pm-Aps Before and After VP-Stimulated Infection

The overlap in protein identification between giVP and giC is shown in Figure 2A. The total number of proteins identified between giVP and giC was 6335, of which 6104 proteins overlapped. There were also 121 proteins that were specific to giC, while a total of 110 specific proteins were identified for giVP. Differentially expressed proteins (DEPs) were screened by the expression fold change (FC) and p < 0.05, with an FC > 2.0 being significantly upregulated and an FC < 0.5 significantly downregulated, and the results are shown in Figure 2B,C. Compared with giC, giVP had a total of 195 DEPs, including 81 significantly upregulated proteins and 114 significantly downregulated proteins, of which 13 proteins had an FC > 10 and 25 proteins had an FC < 0.1. In addition, Table 2 and Table 3 list the major DPEs associated with antimicrobial activity. L-amino-acid oxidase-like isoform X1 (LAAO) expression was the most upregulated, and ribonucleoside-diphosphate reductase large subunit-like (RRM1) expression was the most downregulated. Cluster analysis of the DEPs (Figure 2D) showed that giVP and giC were similarly expressed within the samples and dramatically different compared to their expression between the samples, respectively.

2.4. GO Functional Annotation and Enrichment Analysis

GO functional analysis enables a more comprehensive analysis of the localization, function, and biological pathways involved in DEPs in organisms. The results of the GO function annotation are shown in Figure 3A. DEPs were annotated in biological processes (BPs), such as cellular processes and metabolic processes. The molecular functions (MFs) annotated included catalytic activity, binding, and so on. In addition, DEPs were annotated on cellular component (CC) terms such as cell part, cell, cell membrane, and organelle.
To further analyze the biological pathways by which DEPs exert their antimicrobial functions, all DEPs were enriched for analysis, including BPs, MFs, and CCs, at p < 0.05, and Fisher’s exact test. In Figure 3B, DEPs were mainly enriched on BPs in DNA metabolic processes, DNA-dependent DNA replication, the regulation of RNA splicing, DNA replication, and the regulation of signal transduction by p53 class mediator. Among them, the DNA metabolic process showed the highest enrichment. The MFs included lyase activity, peptide binding, and ribonucleoprotein complex binding. Furthermore, lyase activity was enriched to a higher degree than others. In CC GO terms, DEPs were mainly enriched in distal axons, MCM complexes, and axon parts.

2.5. KEGG Annotation and Enrichment Analysis

The KEGG database is a database of numerous metabolic pathways organized in a specific graphical language, which includes pathway information on multiple aspects of genetic processing, cellular processes, metabolism, and organismal systems. Among the KEGG pathway annotation results (Figure 4A), phagosomes and apoptosis had the most DEPs annotated, followed by the pathways of the tight junction, DNA replication, the gap junction, drug metabolism—other enzymes, the regulation of actin cytoskeleton, and the Rap1 signaling pathway. It is hypothesized that Pm-Aps exerts its antimicrobial effects mainly through the pathways of translocation and catabolism, cell growth and death, cell community (eukaryotic), replication and repair, xenobiotic biodegradation and metabolism, cell motility, and signal transduction. The KEGG pathway significance enrichment level of DEPs was further analyzed at p < 0.05 and tested with Fisher’s exact test. As shown in Figure 4B, the homologous recombination, DNA replication, and mismatch repair pathways underwent dramatically enriched changes.

2.6. Structural Domain Analysis of DEPs

Protein structural domains are closely linked by adjacent supersecondary structures in the polypeptide chain, forming two or more localized regions that can be clearly distinguished in space. Different structural domains bear different biological functions. Therefore, structural domain prediction is of great importance for studying the key functional regions of proteins and the potential biological roles they play. In this study, the software Interproscan (Version 5.59-91.0) [25] was used to predict the structural domains of DEPs, and Fisher’s exact test was used for structural domain enrichment analysis. The enrichment results are shown in Figure 5, the structural domain enrichment mainly included the von Willebrand factor type D domain, C1q domain, cytochrome P450, and FAD binding domain.

2.7. Effect of Catalase on the Activity of Pm-Aps

H2O2 is a strong oxidant that can act as a signaling molecule involved in the oxidative quenching of phagocytes, leading to microbial death [26]. The effect of catalase on the activity of Pm-Aps was explored, and the results are shown in Table 4. The circle of inhibition disappeared after the addition of catalase to Pm-Aps, whereas the circle of inhibition was still produced by Pm-Aps after the addition of an equal amount of sterile PBS. It was hypothesized that some effective components in Pm-Aps might inhibit the growth of microorganisms through the production of H2O2, and the addition of catalase caused the decomposition of H2O2, which resulted in the disappearance of the inhibitory effect.

2.8. Effect of Different Amino Acid Substrates on H2O2 Production by Pm-Aps

The ability of Pm-Aps to generate H2O2 was further explored using 20 L-type amino acids as substrates. As can be seen in Figure 6, Pm-Aps produced H2O2 for all amino acid substrates, while no H2O2 was detected after the addition of catalase (Table S1). It was inferred that Pm-Aps might produce H2O2 by catalyzing the oxidation of amino acids.

3. Discussion

In recent years, the application of natural antimicrobial agents in food processing and aquaculture has received increasing attention. Compared with traditional chemical antimicrobials, novel antimicrobials of natural origin exhibit the advantages of safety, low toxicity, and high activity against drug-resistant bacteria. Therefore, in this study, we utilized VP to stimulate the secretion of Pm-Aps by Pinctada martensii to evaluate its antimicrobial effects, identify the main active components, and explore its potential antimicrobial mechanism.
Firstly, we found that Pm-Aps after VP stimulation possessed higher antimicrobial activity, which is the same as the study by Lin [22]. Further exploration of the effect of Pm-Aps revealed broad-spectrum antimicrobial activity, including strong inhibitory activity against VP, LM, SA, BC, EC, PA, SE, and SI. Pm-Aps had the best inhibitory effect on VP, which might be related to the fact that Pm-Aps was induced to be produced by it. Similar results were found in the study by Zhu Xiaoqi [6], who used EC and inactivated EC to induce the production of antimicrobial peptides by Tenebrio Molitor. And it was found that the concentration of antimicrobial peptides produced by the induced group was significantly higher than that of the uninduced group; at the same time, the antimicrobial peptides produced by the induction inhibited EC better than SA and Salmonella.
Currently, proteomics has been widely used to study the effects of proteins on microorganisms, which helps us to identify DEPs and the relevant functional pathways enriched with them, to mine the core targets of proteins acting on microorganisms, and to understand the relevant mechanisms of action [27]. From the results of proteomics analyses, we found that the expression of L-amino-acid oxidase-like isoform X1 (LAAO), alcohol dehydrogenase (CHDH), toll-like receptor 4 (TLR2), autophagy-related protein 16-1-like (ATG16L1), Bcl-2 homologous antagonist/killer (BAK), calcium-activated chloride channel regulator 1-like (CLCA4), and caspase-8 (CASP8) were significantly upregulated in Pm-Aps after VP stimulation. It has been reported that BAK, CASP8, CHDH, and CLCA4 elevated expression hastens the onset of apoptosis [28,29,30,31,32]. In addition, TLR2 was involved in the recognition of lipopolysaccharide, flagellum, and cell wall components of many bacteria, which is an important protein in the antimicrobial pathway [33]. The overexpression of ATG16L1 could accelerate autophagy to inhibit bacterial growth [34]. Notably, LAAO participated in the oxidative quenching by phagocytes by catalyzing the oxidative deamination of L-type amino acids to produce H2O2, which killed bacteria [26]. On the other hand, zygotic DNA replication licensing factor mcm3 (MCM3), DNA replication licensing factor mcm5-like (MCM5), thymidylate kinase-like (DTYMK), serine/threonine-protein kinase PLK1 (PLK1), F-box only protein 44-like isoform X2 (FBXO6), lysophospholipid acyltransferase 5-like (LPCAT3), glutathione S-transferase theta-1 (GST), regulator complex protein LAMTOR5 homolog (LAMTOR5), steroid 17-alpha-hydroxylase/17,20 lyase-like (CYP17A), lysosomal protective protein isoform X1 (CTSA), and ribonucleoside-diphosphate reductase large subunit-like (RRM1) expression were dramatically downregulated in Pm-Aps. Among them, reduced levels of PLK1, FBXO6, LPCAT3, LAMTOR5, CYP17A, MCM3, MCM5, and DTYMK were able to promote apoptosis [35,36,37,38,39,40,41]. Previous studies have found that GST decreases the antimicrobial effect of antibiotics [42], suggesting that reduced GST expression can improve antimicrobial efficacy. Furthermore, CTSA and RRM1 were found to be associated with autophagy, and a reduction in their expression could facilitate the cellular autophagy process [43,44]. These results suggested that the elevated antimicrobial activity of Pm-Aps may be associated with the upregulated expression of LAAO, CHDH, TLR2, ATG16L1, BAK, CLCA4, and CASP8. It was also associated with the downregulated expression of MCM3, MCM5, DTYMK, PLK1, FBXO6, LPCAT3, GST, LAMTOR5, CYP17A, CTSA, and RRM1.
GO functional analysis revealed that DEPs, through cellular processes, regulate P53-like mediator expression, DNA metabolism, and thus apoptosis and autophagy to resist VP infection. Waveform proteins have been found to resist bacterial infection by participating in many cellular processes, including immune signaling, autophagy, and cell adhesion [45], and P53 could regulate apoptosis and autophagy via modulating various signaling pathways [46], which is similar to our study. Generally, abnormalities in DNA replication and DNA repair (including homologous recombination and mismatch repair) cause apoptosis [47,48]. The PI3K-Akt signaling pathway has a role in modulating inflammation, apoptosis, and oxidative stress [49]. Therefore, the results of KEGG pathway analysis showed that Pm-Aps may accelerate bacterial clearance and autophagy by inhibiting homologous recombination, DNA replication, and mismatch repair pathways, which in turn, promote P53-mediated apoptosis and autophagy. Concurrently, Pm-Aps also instigates inflammatory and oxidative stress responses by regulating phagosomes and the PI3K-Akt signaling pathway [50], which catalyzes the cellular production of excessive ROS to damage proteins, nucleic acids, and lipids and activates apoptotic signaling pathways [51] with the objective of inhibiting bacterial growth.
The von Willebrand factor is a multifunctional protein in plasma that interacts with bacteria, promoting bacterial attachment and exacerbating bacterial infections [52]. The overexpression of CYP 450 has been observed to suppress the innate immune response and exacerbate the severity of bacterial infections [53]. In addition, the C1q structural domain is a prototypical lectin structural domain that serves to recognize pathogens and activate immune signaling pathways [54]. Meanwhile, the FAD binding domain is one of the characteristic structural domains of the LAAO family [55]. The structural domain enrichment results indicated that, when the organism was infected by VP, Pm-Aps induced the organism to produce a substantial number of immune factors to participate in the immune defense against pathogens. This was achieved by downregulating the protein expression of the von Willebrand factor structural domain and CYP 450 as well as upregulating the protein expression of the C1q structural domain and the FAD binding domain.
Of all the DEPs associated with antimicrobial activity, the highest expression was upregulated by LAAO, a common protease in nature that catalyzes the oxidation of L-type amino acids to produce H2O2 [26], which acts as an intracellular signaling molecule involved in the oxidative burst of phagocytosis, thereby inhibiting bacterial growth [26]. By exploring the effect of catalase on Pm-Aps activity, we found that the antimicrobial activity of Pm-Aps disappeared. In addition, Pm-Aps catalyzed the oxidation of a variety of amino acids to generate H2O2, but no H2O2 was detected after the addition of catalase (Table S1). This may be due to the fact that the H2O2 generated from the oxidation of amino acids catalyzed by the LAAO in Pm-Aps was decomposed by catalase, which reduced its antimicrobial activity. A study by Kasai et al. also showed that catalase inhibits the antibacterial activity of LAAO [26]. In summary, we speculated that LAAO in Pm-Aps might kill bacteria by catalyzing the H2O2 produced from the oxidation of amino acid substrates.

4. Materials and Methods

4.1. Strains and Materials

Vibrio parahaemolyticus (VP, GDMCC1.306, gram-negative) was provided by the Guangdong Provincial Strain Collection Center (Guangzhou, China). Listeria monocytogenes (LM, ATCC19111T, gram-positive), Bacillus cereus (BC, CICCG3301T, gram-positive), Staphylococcus aureus (SA, ATCC29213T, gram-positive), Escherichia coli (EC, ATCC35218T, gram-negative), Pseudomonas aeruginosa (PA, ATCC27853T, gram-negative), Streptococcus agalactiae (SE, ATCC12386T, gram-positive), and Streptococcus iniae (SI, ATCC29178T, gram-positive) were acquired from the Food Safety Microbiology Conservation Laboratory, Guangdong Ocean University (Zhanjiang, China). Pinctada martensii was sourced from Zhanjiang, China. Penicillin/streptomycin/gentamicin mixed solution (100× triple antibiotic) and kanamycin solution were purchased from Beijing Solepol Technology Co., Ltd. (Beijing, China). Tryptic soy peptone liquid medium (TSB) and plate counting agar medium were offered by Guangdong Huankai Microbial Technology Co., Ltd. (Guangzhou, China). Trifluoroacetic acid (TFA), hydrogen peroxide (H2O2), formic acid, catalase, 20 amino acids, and acetonitrile were purchased from Shanghai Ron Reagent Co., Ltd. (Shanghai, China). The sterile PBS buffer, H2O2 content determination kit, and BCA protein concentration kit were provided by Biyuntian Biotechnology Co., Ltd. (Shanghai, China). Trypsin, dithiothreitol (DTT), urea, tetraethylammonium bromide, and iodoacetamide were obtained from Sigma-Aldrich Co., Ltd. (St. Louis, MO, USA).

4.2. Strain Activation and Suspension Preparation

VP lyophilized powder was picked and inoculated into TSB (5 mL), which was incubated at 36 °C until turbid, and then the bacterial solution (0.1 mL) was aspirated into sterilized TSB (10 mL) for activation. After the activation was completed, the bacterial solution (2%) was added to the TSB for expansion culture. The resulting bacterial solution was centrifuged to take the precipitate (8000 r/min for 5 min), which was resuspended and diluted to 1 × 1012 cfu/mL with sterile PBS to obtain the VP solution [56].

4.3. VP Stimulates Infection

We used the method of Lin with minor modifications [22]. Pinctada martensii (about 9.5–15.5 cm in shell length, 2.5 years old, from Liusha Bay of Zhanjing City) were rinsed, and the parasitic organisms were removed from their shells for temporary rearing in the preservation room. On the 3rd day of transient rearing, a mixture of antibiotics (0.01%, penicillin/streptomycin/gentamicin/kanamycin mixed solution) was added to the seawater. After 24 h, Pinctada martensii were randomly divided into a control group (giC) and an experimental group (giVp). The giVP group was stimulated with closed-shell muscle injections using VP solution (0.2 mL). The giC group was injected using an equal volume of PBS buffer solution. After injection, they were individually transferred to sterilized, clean seawater for a temporary period of 6 h, and the gill tissues were obtained.

4.4. Antimicrobial Protein Extraction from Gill Tissue

The gill tissue was homogenized with TFA (0.01%) at a ratio of 1:3 (w/v) for 3–5 min; then, the supernatant was centrifuged (8000 r/min, 20min) and lyophilized to obtain the Pm-Aps.

4.5. Effect of VP-Stimulated Infection on the Antimicrobial Activity of Pm-Aps

The antimicrobial activity of Pm-Aps was determined using the micro radial diffusion method. A total of 100 μL of 1 × 108 CFU/mL bacteria suspension was pipetted into 10 mL of sterile trypticase soy agar (plus 3% NaCl for Vibrio strains). The mixture was vortexed and then poured into a petri dish. A total of 10 μL of Pm-Aps sample (with a protein concentration of 100 mg/mL) was pipetted into a well with a diameter of about 3.0 mm; sterile PBS was used as a normal control (NC), and 1.5% H2O2 was used as a positive control (PC). All the test samples were allowed to diffuse at 4 °C for 1 h, and the plates were incubated at 37 °C for 20 h. The diameter of the clear inhibition zone was measured to the nearest 0.1 mm [57].

4.6. Determination of Antimicrobial Spectrum and Antimicrobial Activity of Pm-Aps

The antimicrobial spectrum of Pm-Aps was determined by the trace radial diffusion method as in Section 4.5. Referring to the method of Lin [22] with slight modifications, we determined the antimicrobial activity of Pm-Aps using an inhibitory titer (IT, which was defined as the reciprocal of the highest dilution at which bacterial growth is inhibited (24 h of incubation); the greater the IT, the better its antibacterial activity). The bacterial suspension was prepared as in Section 4.2. The Pm-Aps solution (256 mg/mL) was diluted to 128, 64, 32, 16, and 8 mg/mL. A total of 0.18 mL of Pm-Aps solution and TSB medium were added to the sterile 96-well plate, and 0.02 mL of bacterial suspension was added. Among them, the wells without bacterial solution were negative controls. The absorbance was measured at 600 nm after 24 h of incubation at 37 °C in a thermostat. The difference between the absorbance value of the sample group and the absorbance value of the negative control was less than 0.05, which was considered to be an antibacterial effect.

4.7. Proteomic Analysis

4.7.1. Sample Pre-Treatment

Pm-Aps were trypsinized using the FASP method, and the peptides were desalted and lyophilized using a C18 cartridge (Empore™ SPE Cartridges C18 (standard density), bed I.D. 7 mm, volume 3 mL, Sigma, St. Louis, MO, USA). The lyophilized samples were reconstituted using a 0.1% formic acid solution, and the peptide content was determined at 562 nm [58].

4.7.2. Liquid Chromatography–Mass Spectrometry/Mass Spectrometry (LC–MS/MS)

LC–MS/MS analysis was performed on a timsTOF Pro mass spectrometer coupled to a Nanoelute (Bruker, Billerica, MA, USA) with a coupling time of 120 min. Samples were uploaded in buffer A (0.1% formic acid) onto a reversed-phase trap column (Thermo Scientific Acclaim PepMap100, 100 μm × 2 cm, nanoViper C18, Waltham, MA, USA), which was coupled to a C18 reversed-phase analytical column (Thermo Scientific Easy Column, 10 cm long, 75 μm ID, 3 μm resin). Separation was performed in a linear gradient with buffer B (84% acetonitrile and 0.1% formic acid) at a flow rate of 300 nL/min. The mass spectrometer was operated in the positive ion mode, and ion mobility mass spectra were collected in the mass range of m/z 100–1700, 1/k0 of 0.6–1.6, followed by 10 cycles of PASEF MS/MS with a target intensity of 1.5k, a threshold of 2500, and a release time of 0.4 min.

4.7.3. Protein Identification and Quantification

The identification, retrieval, and quantitative analysis of mass spectrometry data were performed using MaxQuant 1.6.14 software. The parameters were as follows: (i) intact tryptic peptide with up to 2 missing cleavage sites; (ii) Carbamidomethyl (C) as a fixed modification; and (iii) Oxidation (M) as a variable modification. The precursor mass tolerance was set to 20 ppm for the initial search and 6 ppm for the primary search, the MS/MS Tolerance was set to 20 ppm, and the false discovery rate (FDR) was 1%. Quantitative analyses were performed using label-free quantification (LFQ) [59].

4.7.4. Bioinformatics Analysis

Protein clustering analysis was performed using the Complexheatmap R package (R Version 3.4) to classify both samples and protein expression dimensions. Protein structural domains were analyzed using the Pfam database (http://pfam.xfam.org/, accessed on 9 September 2023). Blast2GO (http://www.geneontology.org, accessed on 10 September 2023) was used for the Gene Ontology (GO) functional annotation of the target protein collection. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation of the target protein collection was performed using KEGG Automatic Annotation Server software (https://www.genome.jp/tools/kaas/, accessed on 10 September 2023).

4.8. Determination of the Effect of Catalase on the Antimicrobial Activity of Pm-Aps

The catalase (0.01 g) was dissolved in PBS (1 mL) and mixed well. The antimicrobial activity was determined by the micro radial diffusion method with reference to Section 4.5. Pm-Aps (0.01 mL, 64 mg/mL) and PBS (4 μL) were added to the sample group, while Pm-Aps (0.01 mL, 64 mg/mL) and catalase (4 μL, 10 mg/mL) were added to the control group [60].

4.9. The Effect of Different Amino Acid Substrates on H2O2 Production by Pm-Aps

Pm-Aps solution (25 μL, 64 mg/mL), amino acid solution (25 μL, 20 mmol/L), and PBS (25 μL) were mixed as the sample group, and the control group was added with Pm-Aps solution (25 μL, 64 mg/mL), amino acid solution (25 μL, 20 mmol/L), and catalase (25 μL, 10 mg/mL), while the H2O2 concentration resulting from the reaction was measured according to the H2O2 content determination kit instructions [61].

4.10. Statistical Analysis

All data were replicated three times, and results were expressed as mean ± standard deviation (SD). Graphs were plotted using Graphpad Prism 9.0, and experimental data were analyzed by one-way ANOVA with post hoc comparisons using Duncan’s method using SPSS 26.0 software. p < 0.05 was considered significant.

5. Conclusions

In this study, we used VP to stimulate Pinctada martensii and extracted Pm-Aps from gill tissues to determine their antimicrobial activities. It was found that the antimicrobial activity of Pm-Aps was significantly elevated after VP stimulation, and it had high broad-spectrum antimicrobial activity. Proteomic analysis showed that enhanced Pm-Aps activity was mainly associated with the upregulation of the expression of LAAO, CHDH, TLR2, ATG16L1, BAK, CLCA4, and CASP8 as well as the downregulation of the expression of MCM3, MCM5, DTYMK, PLK1, FBXO6, LPCAT3, GST, LAMTOR5, CYP17A, CTSA, and RRM1. It is hypothesized that the related proteins inhibit bacterial growth and reproduction by hindering DNA replication and repair, inducing apoptosis and autophagy, and activating immune-related signaling pathways. In addition, we found that the key component of Pm-Aps exerting antimicrobial effects is LAAO, which exerts bactericidal effects by catalyzing the oxidation of amino acids to generate H2O2. In conclusion, these findings provide some theoretical basis for the development of Pm-Aps.
However, the current study still has some limitations. The proteomics results still need to be further validated and analyzed, and Pm-Aps need to be isolated and purified. Thus, in the next step, the proteomics results (DEPs) can be validated using methods such as the Quantitative Polymerase Chain Reaction (qPCR) and the Western Blot (WB). Secondly, LAAO was obtained by isolation and purification of Pm-Aps using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). In addition, we can also obtain the full length of the gene of LAAO in Pm-Aps by cloning, and the full length of its cDNA sequence could be analyzed by bioinformatics, which is expected to prepare recombinant LAAO efficiently by constructing prokaryotic and eukaryotic expression systems.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics13111100/s1. Table S1: Levels of H2O2 production by different amino acid substrates.

Author Contributions

Conceptualization, H.L.; methodology, H.L., W.S. and B.L.; software, validation, and formal analysis, W.S. and B.L.; investigation, H.L., W.S. and B.L.; resources, H.L. and X.Q.; data curation and writing—original draft preparation, W.S. and H.L.; writing—review and editing, X.Q., J.G., W.C., H.Z., Z.C. and B.S.; visualization, B.L.; supervision, project administration, and funding acquisition, H.L., H.Z. and X.Q., and B.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Natural Science Foundation of Guangdong Province, China (Grant No. 2021A1515012137), the earmarked fund for the China Agriculture Research System (CARS-49), the scientific research start-up funds of Guangdong Ocean University (Grant. No. 060302042106 and No. R17082), and the Guangdong Province Modern Agricultural Industry Technology System Innovation Team Construction Project (Grant No. 2023KJ146).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are available upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Motta, J.-P.; Wallace, J.L.; Buret, A.G.; Deraison, C.; Vergnolle, N. Gastrointestinal biofilms in health and disease. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 314–334. [Google Scholar] [CrossRef] [PubMed]
  2. Chen, Y.Q.; Liu, Z.X.; Lin, Z.X.; Lu, M.C.; Fu, Y.; Liu, G.Q.; Yu, B. The effect of Staphylococcus aureus on innate and adaptive immunity and potential immunotherapy for S. aureus-induced osteomyelitis. Front. Immunol. 2023, 14, 1219895. [Google Scholar] [CrossRef] [PubMed]
  3. Vijayaram, S.; Chou, C.C.; Razafindralambo, H.; Ghafarifarsani, H.; Divsalar, E.; Van Doan, H. Bacillus sp. as potential probiotics for use in tilapia fish farming aquaculture—A review. Ann. Anim. Sci. 2024, 24, 995–1006. [Google Scholar] [CrossRef]
  4. Wu, R.A.; Feng, J.; Yue, M.; Liu, D.; Ding, T. Overuse of food-grade disinfectants threatens a global spread of antimicrobial-resistant bacteria. Crit. Rev. Food Sci. Nutr. 2024, 64, 6870–6879. [Google Scholar] [CrossRef]
  5. Fathurrahman, R.N.; Rukayadi, Y.; Fatimah, U.Z.A.U.; Jinap, S.; Abdul-Mutalib, N.A.; Sanny, M. The performance of food safety management system in relation to the microbiological safety of salmon nigiri sushi: A multiple case study in a Japanese chain restaurant. Food Control 2021, 127, 108111. [Google Scholar] [CrossRef]
  6. Zhu, X.; Zhao, X.; Wu, Y.; Xie, C.; Chen, X.; Wang, J.; Shen, H. The Extraction of Antimicrobial Peptide of Tenebrio molitor Induced by E.coli and the Determination of Its Antibacterial Activity. J. Shihezi Univ. (Nat. Sci.) 2014, 4, 444–448. [Google Scholar]
  7. Liu, J.; Liu, G.; Cao, Y.; Du, H.; Liu, T.; Liu, M.; Li, P.; He, Y.; Wang, G.; Yu, Q.; et al. BNC-rSS, a bivalent subunit nanovaccine affords the cross-protection against Streptococcus agalactiae and Streptococcus iniae infection in tilapia. Int. J. Biol. Macromol. 2023, 253, 126670. [Google Scholar] [CrossRef]
  8. Tang, Y.J.; Ali, Z.; Zou, J.; Jin, G.; Zhu, J.C.; Yang, J.; Dai, J.G. Detection methods for Pseudomonas aeruginosa: History and future perspective. RSC Adv. 2017, 7, 51789–51800. [Google Scholar] [CrossRef]
  9. Wang, Y.; Gu, M.; Cheng, J.; Wan, Y.; Zhu, L.; Gao, Z.; Jiang, L. Antibiotic Alternatives: Multifunctional Ultra-Small Metal Nanoclusters for Bacterial Infectious Therapy Application. Molecules 2024, 29, 3117. [Google Scholar] [CrossRef]
  10. Ebrahimpour-koujan, S.; Saneei, P.; Larijani, B.; Esmaillzadeh, A. Consumption of sugar sweetened beverages and dietary fructose in relation to risk of gout and hyperuricemia: A systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 2020, 60, 1–10. [Google Scholar] [CrossRef]
  11. Ahmad, V.; Khan, M.S.; Jamal, Q.M.S.; Alzohairy, M.A.; Al Karaawi, M.A.; Siddiqui, M.U. Antimicrobial potential of bacteriocins: In therapy, agriculture and food preservation. Int. J. Antimicrob. Ag. 2017, 49, 1–11. [Google Scholar] [CrossRef] [PubMed]
  12. Hoskin, D.W.; Ramamoorthy, A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta (BBA)-Biomembr. 2008, 1778, 357–375. [Google Scholar] [CrossRef] [PubMed]
  13. Brogden, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238–250. [Google Scholar] [CrossRef] [PubMed]
  14. Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. Antimicrobial Peptides: An Emerging Category of Therapeutic Agents. Front. Cell. Infect. Microbiol. 2016, 6, 194. [Google Scholar] [CrossRef] [PubMed]
  15. Le, C.-F.; Fang, C.-M.; Sekaran, S.D. Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob. Agents Chemother 2017, 61, e02340. [Google Scholar] [CrossRef]
  16. Jin, Z.; Shen, M.; Wang, L.; Wang, C.; Gao, M.; Yu, G.; Chang, Z.; Zhang, X. Antibacterial and immunoregulatory activity of an antimicrobial peptide hepcidin in loach (Misgurnus anguillicaudatus). Int. J. Biol. Macromol. 2023, 242, 124833. [Google Scholar] [CrossRef]
  17. Chen, Z.; Wang, L.; He, D.; Liu, Q.; Han, Q.; Zhang, J.; Zhang, A.M.; Song, Y. Exploration of the Antibacterial and Anti-Inflammatory Activity of a Novel Antimicrobial Peptide Brevinin-1BW. Molecules 2024, 29, 1534. [Google Scholar] [CrossRef]
  18. Hugo, C.J.; Hugo, A. Current trends in natural preservatives for fresh sausage products. Trends Food Sci. Technol. 2015, 45, 12–23. [Google Scholar] [CrossRef]
  19. Hu, J.; Li, S.; Lv, Q.; Miao, M.; Li, X.; Li, F. Characterization of the Dual Functions of LvCrustinVII from Litopenaeus vannamei as Antimicrobial Peptide and Opsonin. Mar. Drugs 2022, 20, 157. [Google Scholar] [CrossRef]
  20. Nakagawa, A.; Sakamoto, T.; Kanost, M.R.; Tabunoki, H. The Development of New Methods to Stimulate the Production of Antimicrobial Peptides in the Larvae of the Black Soldier Fly Hermetia illucens. Int. J. Mol. Sci. 2023, 24, 15765. [Google Scholar] [CrossRef]
  21. Li, L.Z.; Meng, H.M.; Gu, D.; Li, Y.; Jia, M.D. Molecular mechanisms of Vibrio parahaemolyticus pathogenesis. Microbiol Res 2019, 222, 43–51. [Google Scholar] [CrossRef] [PubMed]
  22. Lin, H.S.; Ishizaki, S.; Nagashima, Y.; Nagai, K.; Maeyama, K.; Watabe, S. Exploration of the antibacterial proteins in pearl oyster induced by bacterial inoculation. Fish. Sci 2017, 83, 489–498. [Google Scholar] [CrossRef]
  23. Liang, H.Y.; Zhang, M.Z.; Shen, C.H.; He, J.J.; Lu, J.Z.; Guo, Z.J. Cloning and functional analysis of a trypsin-like serine protease from. Fish Shellfish Immun. 2022, 126, 327–335. [Google Scholar] [CrossRef] [PubMed]
  24. Shen, C.; Guo, Z.; Liang, H.; Zhang, M. Preliminary investigation of the immune activity of PmH2A-derived antimicrobial peptides from the pearl oyster Pinctada fucata martensii. Fish Shellfish Immun. 2023, 135, 108691. [Google Scholar] [CrossRef]
  25. Finn, R.D.; Coggill, P.; Eberhardt, R.Y.; Eddy, S.R.; Mistry, J.; Mitchell, A.L.; Potter, S.C.; Punta, M.; Qureshi, M.; Sangrador-Vegas, A.; et al. The Pfam protein families database: Towards a more sustainable future. Nucleic Acids Res. 2016, 44, 279–285. [Google Scholar] [CrossRef]
  26. Kasai, K.; Nakano, M.; Ohishi, M.; Nakamura, T.; Miura, T. Antimicrobial properties of L-amino acid oxidase: Biochemical features and biomedical applications. Appl. Microbiol. Biotechnol. 2021, 105, 4819–4832. [Google Scholar] [CrossRef]
  27. Roukos, D.H.; Baltogiannis, G.G.; Katsouras, C.S.; Bechlioulis, A.; Naka, K.K.; Batsis, C.; Liakakos, T.; Michalis, L.K. Novel Next-Generation Sequencing and Networks-Based Therapeutic Targets: Realistic and More Effective Drug Design and Discovery. Curr. Pharm. Des. 2014, 20, 11–22. [Google Scholar] [CrossRef]
  28. Iyer, S.; Uren, R.T.; Dengler, M.A.; Shi, M.X.; Uno, E.; Adams, J.M.; Dewson, G.; Kluck, R.M. Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target. Cell Death Dis. 2020, 11, 268. [Google Scholar] [CrossRef]
  29. Zhang, R.W.; Ren, A.H.; Wang, Z.H.; Wang, D.W. Overexpression of Calcium Activated Chloride Channel A4 Suppressed the Proliferation, Invasion and Gemcitabine Resistance of Non-Small Cell Lung Cancer Cells. J. Biomater. Tiss. Eng. 2020, 10, 435–442. [Google Scholar] [CrossRef]
  30. Song, J.; Zhang, J.; Shi, J.; Pan, X.; Mo, D. Breviscapine Reduces Sepsis-Induced Acute Lung Injury by Targeting CASP8 to Regulate Neutrophil Apoptosis and Inflammation. J. Inflamm. Res. 2024, 17, 5161–5176. [Google Scholar] [CrossRef]
  31. Liao, Y.F.; Lai, Y.Y.; Xu, H.L.; Gao, L.; Fu, X.M.; Wang, X.; Wang, Q.; Shen, J.A.; Fang, J.S.; Fang, S.H. Bushen-Yizhi formula ameliorates mitochondrial dysfunction and oxidative stress via AMPK/Sirt1 signaling pathway in D-gal-induced aging rats. Chin. Med. 2023, 18, 53. [Google Scholar] [CrossRef] [PubMed]
  32. Wu, P.; Chen, J.N.; Chen, J.J.; Tao, J.; Wu, S.Y.; Xu, G.S.; Wang, Z.; Wei, D.H.; Yin, W.D. Trimethylamine N-oxide promotes apoE mice atherosclerosis by inducing vascular endothelial cell pyroptosis via the SDHB/ROS pathway. J. Cell Physiol. 2020, 235, 6582–6591. [Google Scholar] [CrossRef] [PubMed]
  33. Guo, S.; Yang, Q.; Fan, Y.; Ran, M.; Shi, Q.; Song, Z. Characterization and expression profiles of toll-like receptor genes (TLR2 and TLR5) in immune tissues of hybrid yellow catfish under bacterial infection. Fish Shellfish Immun. 2024, 150, 109627. [Google Scholar] [CrossRef] [PubMed]
  34. Zhang, H.; Wang, D.; Shihb, D.Q.; Zhang, X.L. Atg16l1 in dendritic cells is required for antibacterial defense and autophagy in murine colitis. Iubmb. Life 2020, 72, 2686–2695. [Google Scholar] [CrossRef] [PubMed]
  35. Ulu, Z.O.; Bolat, Z.B.; Sahin, F. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of sodium perborate on hepatocellular carcinoma cells. J. Trace Elem. Med. Bio. 2022, 73, 127011. [Google Scholar]
  36. Chow, L.W.C.; Loo, W.T.Y.; Yip, A.Y.S.; Ong, E.Y.Y.; Ng, W. 23P Expression Of Beta-Iii Tubulin, Foxo 3 Protein and Deoxythymidine Kinase in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Ann. Oncol. 2012, 23, ii21. [Google Scholar] [CrossRef]
  37. Moolmuang, B.; Chaisaingmongkol, J.; Singhirunnusorn, P.; Ruchirawat, M. PLK1 inhibition leads to mitotic arrest and triggers apoptosis in cholangiocarcinoma cells. Oncol. Lett. 2024, 28, 316. [Google Scholar] [CrossRef]
  38. Cen, M.; Ouyang, W.; Lin, X.; Du, X.; Hu, H.; Lu, H.; Zhang, W.; Xia, J.; Qin, X.; Xu, F. FBXO6 regulates the antiviral immune responses via mediating alveolar macrophages survival. J. Med. Virol. 2023, 95, e28203. [Google Scholar] [CrossRef]
  39. Gao, E.M.; Turathum, B.; Wang, L.; Zhang, D.; Liu, Y.B.; Tang, R.X.; Chian, R.C. The Differential Metabolomes in Cumulus and Mural Granulosa Cells from Human Preovulatory Follicles. Reprod. Sci. 2022, 29, 1343–1356. [Google Scholar] [CrossRef]
  40. Wang, X.; Li, Q.-Q.; Tang, Y.-X.; Li, Y.; Zhang, L.; Xu, F.-F.; Fu, X.-L.; Ye, K.; Ma, J.-Q.; Guo, S.-M.; et al. Oncoprotein LAMTOR5-mediated CHOP silence via DNA hypermethylation and miR-182/miR-769 in promotion of liver cancer growth. Acta. Pharmacol. Sin. 2024. [Google Scholar] [CrossRef]
  41. Harrath, A.H.; Jalouli, M.; Oueslati, M.H.; Farah, M.A.; Feriani, A.; Aldahmash, W.; Aldawood, N.; Al-Anazi, K.; Falodah, F.; Swelum, A.; et al. The flavonoid, kaempferol-3-O-apiofuranosyl-7-O-rhamnopyranosyl, as a potential therapeutic agent for breast cancer with a promoting effect on ovarian function. Phytother. Res. 2021, 35, 6170–6180. [Google Scholar] [CrossRef] [PubMed]
  42. Pugazhendhi, A.; Dhanarani, S.; Shankar, C.; Prakash, P.; Ranganathan, K.; Saratale, R.G.; Thamaraiselvi, K. Electrophoretic pattern of glutathione S-transferase (GST) in antibiotic resistance Gram-positive bacteria from poultry litter. Microb. Pathog. 2017, 110, 285–290. [Google Scholar] [CrossRef] [PubMed]
  43. You, Y.; Li, W.-Z.; Zhang, S.; Hu, B.; Li, Y.-X.; Li, H.-D.; Tang, H.-H.; Li, Q.-W.; Guan, Y.-Y.; Liu, L.-X.; et al. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy. J. Hepatol. 2018, 69, 129–141. [Google Scholar] [CrossRef] [PubMed]
  44. Takahashi, T.; Ando, Y.; Ichikawa, H.; Tsuneyama, K.; Hijikata, T. Serum/glucose starvation strikingly reduces heterogeneous nuclear ribonucleoprotein A1 protein and its target, cyclin D1. Febs. J. 2023, 290, 4126–4144. [Google Scholar] [CrossRef]
  45. Mak, T.N.; Brüggemann, H. Vimentin in Bacterial Infections. Cells 2016, 5, 18. [Google Scholar] [CrossRef]
  46. Cao, L.; Fang, H.; Yan, D.; Wu, X.M.; Zhang, J.; Chang, M.X. CD44a functions as a regulator of p53 signaling, apoptosis and autophagy in the antibacterial immune response. Commun. Biol. 2022, 5, 889. [Google Scholar] [CrossRef]
  47. Hao, Y.Q.; Guo, H.M.; Hong, Y.C.; Fan, X.; Su, Y.M.; Yang, X.S.; Ren, G.X. Lunasin peptide promotes lysosome-mitochondrial mediated apoptosis and mitotic termination in MDA-MB-231 cells. Food Sci. Hum. Wellness 2022, 11, 1598–1606. [Google Scholar] [CrossRef]
  48. Mosca, L.; Pagano, C.; Tranchese, R.V.; Grillo, R.; Cadoni, F.; Navarra, G.; Coppola, L.; Pagano, M.; Mele, L.; Cacciapuoti, G.; et al. Antitumoral Activity of the Universal Methyl Donor S-Adenosylmethionine in Glioblastoma Cells. Molecules 2024, 29, 1708. [Google Scholar] [CrossRef]
  49. Huo, C.L.; Wang, B.; Zhang, X.W.; Sun, Z.G. Skimmianine attenuates liver ischemia/reperfusion injury by regulating PI3K-AKT signaling pathway-mediated inflammation, apoptosis and oxidative stress. Sci. Rep. 2023, 13, 18232. [Google Scholar] [CrossRef]
  50. Wang, X.; Liu, W.; Zhang, D.; Jiao, Y.L.; Zhao, Q.H.; Liu, Y.; Shi, W.Y.; Bao, Y.Z. Salvia miltiorrhiza polysaccharides alleviate florfenicol-induced inflammation and oxidative stress in chick livers by regulating phagosome signaling pathway. Ecotox Env. Safe 2023, 249, 114428. [Google Scholar] [CrossRef]
  51. Redza-Dutordoir, M.; Averill-Bates, D.A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim. Biophys. Acta. 2016, 1863, 2977–2992. [Google Scholar] [CrossRef] [PubMed]
  52. Steinert, M.; Ramming, I.; Bergmann, S. Impact of Von Willebrand Factor on Bacterial Pathogenesis. Front. Med. 2020, 7, 543. [Google Scholar] [CrossRef] [PubMed]
  53. Lucarelli, R.; Gorrochotegui-Escalante, N.; Taddeo, J.; Buttaro, B.; Beld, J.; Tam, V. Eicosanoid-Activated PPARα Inhibits NFκB-Dependent Bacterial Clearance During Post-Influenza Superinfection. Front. Cell. Infect. Microbiol. 2022, 12, 881462. [Google Scholar] [CrossRef] [PubMed]
  54. Grinchenko, A.; Buriak, I.; Kumeiko, V. Invertebrate C1q Domain-Containing Proteins: Molecular Structure, Functional Properties and Biomedical Potential. Mar. Drugs 2023, 21, 570. [Google Scholar] [CrossRef] [PubMed]
  55. Hou, Y.L.; Gao, Y.Q.; Jin, S.B.; Li, A.X.; Li, R.J. L-amino acid oxidase as an enzyme related to innate immune defense in marine animals:research progress. J. Dalian Ocean Univ. 2017, 32, 625–630. [Google Scholar]
  56. Hamad, G.M.; Abushaala, N.M.; Soltan, O.I.A.; Abdel-Hameed, S.M.; Magdy, R.M.E.; Ahmed, E.M.H.; Elshaer, S.E.; Kamar, A.M.; Hashem, R.M.A.; Elghazaly, E.M.; et al. Prevalence and antibacterial effect of natural extracts against Vibrio parahaemolyticus and its application on Tilapia Fillets. LWT-Food Sci. Technol. 2024, 209, 116812. [Google Scholar] [CrossRef]
  57. Li, M.R.; Zhou, R.A.; Wang, Y.Y.; Lu, Y.; Chu, X.L.; Dong, C.M. Heterologous expression of frog antimicrobial peptide Odorranain-C1 in Pichia pastoris: Biological characteristics and its application in food preservation. J. Biotechnol 2024, 390, 50–61. [Google Scholar] [CrossRef]
  58. He, R.; Chen, H.; Wu, H.; Liu, J.; Chen, W.; Zhang, M.; Chen, W.; Zhong, Q. Proteomics reveals energy limitation and amino acid consumption as antibacterial mechanism of linalool against Shigella sonnei and its application in fresh beef preservation. Food Chem. X 2023, 19, 100837. [Google Scholar] [CrossRef]
  59. Piras, C.; De Fazio, R.; Di Francesco, A.; Oppedisano, F.; Spina, A.A.; Cunsolo, V.; Roncada, P.; Cramer, R.; Britti, D. Detection of Antimicrobial Proteins/Peptides and Bacterial Proteins Involved in Antimicrobial Resistance in Raw Cow’s Milk from Different Breeds. Antibiotics 2024, 13, 838. [Google Scholar] [CrossRef]
  60. Grabek-Lejko, D.; Hyrchel, T. The Antibacterial Properties of Polish Honey against Streptococcus mutans—A Causative Agent of Dental Caries. Antibiotics 2023, 12, 1640. [Google Scholar] [CrossRef]
  61. Osés, S.M.; Rodríguez, C.; Valencia, O.; Fernández-Muiño, M.A.; Sancho, M.T. Relationships among Hydrogen Peroxide Concentration, Catalase, Glucose Oxidase, and Antimicrobial Activities of Honeys. Foods 2024, 13, 1344. [Google Scholar] [CrossRef]
Figure 1. The effect of VP-stimulated infection on Pm-Aps activity. Normal control (NC): sterile PBS; positive control (PC): 1.5% H2O2; control group (giC): no VP-stimulated Pm-Aps; experimental group (giVP): VP-stimulated Pm-Aps. Different alphabets indicate significant differences (p < 0.05).
Figure 1. The effect of VP-stimulated infection on Pm-Aps activity. Normal control (NC): sterile PBS; positive control (PC): 1.5% H2O2; control group (giC): no VP-stimulated Pm-Aps; experimental group (giVP): VP-stimulated Pm-Aps. Different alphabets indicate significant differences (p < 0.05).
Antibiotics 13 01100 g001
Figure 2. Screening of DEPs before and after VP-stimulated infection. (A) Venn diagram of proteins identified in giVP and giC. (B) Histogram of DEPs results. Upregulated DEPs are in red, and downregulated DEPs are in blue. (C) Volcano map of DEPs. Red dots are significant upregulated DEPs (FC > 2.0 and p < 0.05), blue dots are prominent downregulated DEPs (FC < 0.5 and p < 0.05), and gray dots are proteins with no differential change. The details of the labeled proteins are shown in Table 2 and Table 3. (D) Hierarchical cluster analysis heatmap of DEPs. A redder color means that the protein is upregulated for significance in this sample, and a bluer color means that the protein is downregulated for significance in this sample. Control group (giC): no VP-stimulated Pm-Aps; experimental group (giVP): VP-stimulated Pm-Aps.
Figure 2. Screening of DEPs before and after VP-stimulated infection. (A) Venn diagram of proteins identified in giVP and giC. (B) Histogram of DEPs results. Upregulated DEPs are in red, and downregulated DEPs are in blue. (C) Volcano map of DEPs. Red dots are significant upregulated DEPs (FC > 2.0 and p < 0.05), blue dots are prominent downregulated DEPs (FC < 0.5 and p < 0.05), and gray dots are proteins with no differential change. The details of the labeled proteins are shown in Table 2 and Table 3. (D) Hierarchical cluster analysis heatmap of DEPs. A redder color means that the protein is upregulated for significance in this sample, and a bluer color means that the protein is downregulated for significance in this sample. Control group (giC): no VP-stimulated Pm-Aps; experimental group (giVP): VP-stimulated Pm-Aps.
Antibiotics 13 01100 g002
Figure 3. GO functional annotation and enrichment analysis of DEPs. (A) GO annotations of statistical analysis of DEPs. (B) GO functional enrichment of DEPs. A BP is a biological process, an MF is a molecular function, and a CC is a cellular component; the number Rich factor, above the bars, is the number of relevant differential proteins as a proportion of all characterized proteins for that GO term.
Figure 3. GO functional annotation and enrichment analysis of DEPs. (A) GO annotations of statistical analysis of DEPs. (B) GO functional enrichment of DEPs. A BP is a biological process, an MF is a molecular function, and a CC is a cellular component; the number Rich factor, above the bars, is the number of relevant differential proteins as a proportion of all characterized proteins for that GO term.
Antibiotics 13 01100 g003
Figure 4. KEGG annotation and enrichment analysis of DEPs. (A) KEGG annotations of statistical analysis of DEPs. (B) KEGG pathway enrichment of DEPs. The rich factor is the ratio of the number of relevant differential proteins to the number of characterized proteins in the pathway.
Figure 4. KEGG annotation and enrichment analysis of DEPs. (A) KEGG annotations of statistical analysis of DEPs. (B) KEGG pathway enrichment of DEPs. The rich factor is the ratio of the number of relevant differential proteins to the number of characterized proteins in the pathway.
Antibiotics 13 01100 g004
Figure 5. Structural domain enrichment bubble diagram of DEPs. The rich factor is the ratio of the number of relevant differential proteins to the number of all characterized proteins in that structural domain.
Figure 5. Structural domain enrichment bubble diagram of DEPs. The rich factor is the ratio of the number of relevant differential proteins to the number of all characterized proteins in that structural domain.
Antibiotics 13 01100 g005
Figure 6. The effect of different amino acid substrates on H2O2 concentration. Different alphabets indicate significant differences (p < 0.05).
Figure 6. The effect of different amino acid substrates on H2O2 concentration. Different alphabets indicate significant differences (p < 0.05).
Antibiotics 13 01100 g006
Table 1. Antimicrobial spectrum and antimicrobial activity of Pm-Aps.
Table 1. Antimicrobial spectrum and antimicrobial activity of Pm-Aps.
StrainDiameter (mm)IT
Vibrio parahaemolyticus (VP)11.51 ± 0.5416
Listeria monocytogenes (LM)7.40 ± 0.108
Staphylococcus aureus (SA)7.50 ± 0.108
Bacillus cereus (BC)5.43 ± 0.054
Escherichia coli (EC)4.23 ± 0.054
Pseudomonas aeruginosa (PA)5.30 ± 0.104
Streptococcus agalactiae (SE)6.37 ± 0.114
Streptococcus iniae (SI)5.20 ± 0.104
Inhibitory titer (IT) was defined as the reciprocal of the highest dilution to inhibit the growth of bacteria (incubated for 24 h); the greater the IT, the higher the inhibitory activity.
Table 2. Key DEPs with upregulated expression.
Table 2. Key DEPs with upregulated expression.
ProteinGeneDescriptiongiVp/giC (FC)
TR14358_c0_g1_ORFLAAOL-amino-acid oxidase-like isoform X14.670
TR24434_c0_g1_ORF_1CHDHalcohol dehydrogenase4.278
TR7325_c1_g1_ORFTLR2toll-like receptor 44.234
TR38222_c0_g1_ORFATG16L1autophagy-related protein 16-1-like3.554
TR7164_c0_g1_ORFBAKBcl-2 homologous antagonist/killer2.460
TR1646_c0_g1_ORFCLCA4calcium-activated chloride channel regulator 1-like2.282
TR775_c1_g1_ORFCASP8caspase-82.086
Table 3. Key DEPs with downregulated expression.
Table 3. Key DEPs with downregulated expression.
ProteinGeneDescriptiongiVp/giC (FC)
TR10572_c0_g1_ORFMCM3zygotic DNA replication licensing factor mcm30.469
TR4065_c0_g1_ORFMCM5DNA replication licensing factor mcm5-like0.466
TR73065_c0_g2_ORFDTYMKthymidylate kinase-like0.369
TR3406_c0_g1_ORFPLK1serine/threonine-protein kinase PLK10.351
TR20414_c0_g1_ORFFBXO6F-box only protein 44-like isoform X20.329
TR6309_c1_g2_ORFLPCAT3lysophospholipid acyltransferase 5-like0.308
TR13088_c0_g1_ORFGSTglutathione S-transferase theta-10.281
TR41412_c0_g2_ORFLAMTOR5regulator complex protein LAMTOR5 homolog0.263
TR8221_c0_g1_ORFCYP17Asteroid 17-alpha-hydroxylase/17,20 lyase-like0.152
TR19429_c0_g1_ORFCTSAlysosomal protective protein isoform X10.090
TR16486_c0_g1_ORFRRM1ribonucleoside-diphosphate reductase large subunit-like0.015
Table 4. The effect of catalase on the antimicrobial activity of Pm-Aps.
Table 4. The effect of catalase on the antimicrobial activity of Pm-Aps.
StrainDiameter (mm)
Pm-Aps and PBSPm-Aps and Catalase
Vibrio parahaemolyticus (VP)10.13 ± 0.05-
Listeria monocytogenes (LM)6.20 ± 0.10-
Staphylococcus aureus (SA)5.83 ± 0.05-
Bacillus cereus (BC)4.50 ± 0.10-
Escherichia coli (EC)3.53 ± 0.05-
Pseudomonas aeruginosa (PA)4.20 ± 0.10-
Streptococcus agalactiae (SE)5.33 ± 0.15-
Streptococcus iniae (SI)4.26 ± 0.05-
“-” indicates no antimicrobial activity.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lin, H.; Shen, W.; Luo, B.; Cao, W.; Qin, X.; Gao, J.; Chen, Z.; Zheng, H.; Song, B. Proteomic Analysis of Vibrio parahaemolyticus-Stimulated Pinctada martensii Proteins for Antimicrobial Activity, Potential Mechanisms, and Key Components. Antibiotics 2024, 13, 1100. https://doi.org/10.3390/antibiotics13111100

AMA Style

Lin H, Shen W, Luo B, Cao W, Qin X, Gao J, Chen Z, Zheng H, Song B. Proteomic Analysis of Vibrio parahaemolyticus-Stimulated Pinctada martensii Proteins for Antimicrobial Activity, Potential Mechanisms, and Key Components. Antibiotics. 2024; 13(11):1100. https://doi.org/10.3390/antibiotics13111100

Chicago/Turabian Style

Lin, Haisheng, Weiqiang Shen, Bei Luo, Wenhong Cao, Xiaoming Qin, Jialong Gao, Zhongqin Chen, Huina Zheng, and Bingbing Song. 2024. "Proteomic Analysis of Vibrio parahaemolyticus-Stimulated Pinctada martensii Proteins for Antimicrobial Activity, Potential Mechanisms, and Key Components" Antibiotics 13, no. 11: 1100. https://doi.org/10.3390/antibiotics13111100

APA Style

Lin, H., Shen, W., Luo, B., Cao, W., Qin, X., Gao, J., Chen, Z., Zheng, H., & Song, B. (2024). Proteomic Analysis of Vibrio parahaemolyticus-Stimulated Pinctada martensii Proteins for Antimicrobial Activity, Potential Mechanisms, and Key Components. Antibiotics, 13(11), 1100. https://doi.org/10.3390/antibiotics13111100

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop